These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 8510322

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Evaluation of cefoperazone in the treatment of bacterial infections in patients with hematological diseases.
    Ichimaru M, Takatsuki K, Niho Y, Sawae Y.
    Clin Ther; 1984; 7(1):60-8. PubMed ID: 6518464
    [Abstract] [Full Text] [Related]

  • 23. [Clinical effects of a combination treatment with fosfomycin and clavulanic acid/ticarcillin for infections in patients complicated with hematological disorders].
    Hirakawa K, Tsuda S, Misawa S, Ueda Y, Kaneko H, Nakao M, Ariyama Y, Nakai H, Seriu T, Takashima T.
    Jpn J Antibiot; 1994 May; 47(5):521-9. PubMed ID: 8051794
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Randomized comparison of piperacillin-tazobactam plus amikacin versus cefoperazone-sulbactam plus amikacin for management of febrile neutropenia in children with lymphoma and solid tumors.
    Demirkaya M, Celebi S, Sevinir B, Hacımustafaoglu M.
    Pediatr Hematol Oncol; 2013 Mar; 30(2):141-8. PubMed ID: 23301757
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Fundamental and clinical studies of sulbactam/cefoperazone in obstetrics and gynecology].
    Kubota K.
    Jpn J Antibiot; 1984 Nov; 37(11):2234-42. PubMed ID: 6098717
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Therapeutic evaluation of imipenem/cilastatin sodium for bacterial infections in patients with hematological diseases].
    Sawae Y, Niho Y, Harada M, Shibuya T, Okamura T, Asano Y, Taniguchi S, Murakawa M, Toyoshima T, Kozuru M.
    Jpn J Antibiot; 1992 Feb; 45(2):123-35. PubMed ID: 1613965
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Clinical studies on sulbactam/cefoperazone in the field of obstetrics and gynecology].
    Ikushima Y, Kobayashi H, Matsumoto S, Shirakawa K.
    Jpn J Antibiot; 1984 Nov; 37(11):2251-5. PubMed ID: 6098719
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Clinical studies of sulbactam/cefoperazone in the field of obstetrics and gynecology].
    Fukuda O, Shimokawa K, Inoue S, Maeyama M.
    Jpn J Antibiot; 1984 Oct; 37(10):1977-82. PubMed ID: 6094877
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Clinical evaluation of ceftazidime monotherapy for infections complicated with hematological disorders].
    Kuzuyama Y, Tsuda S, Seriu T, Nakai H, Murakami T, Takashima T, Takahashi Y, Tanaka S, Nakagawa H, Nishigaki H.
    Jpn J Antibiot; 1992 May; 45(5):523-9. PubMed ID: 1512938
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.